{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/123-US9,535,057(active).pdf"}, "page_content": "micromanipulator. Pressure change in the blood vessel will\n\ncalcium channels. Thus, emphasis is put on the preclinical\n\nmove the interface between the plasma and NaCl solution,\n\nscreening for new therapeutic compounds with any unex\n\nresulting in the change of electrical resistance of the elec\n\npected cardiac toxic effects by highly sensitive and specific\n\ntrode inside the glass capillary. Recently, methodology for\n\n45\n\nexperimental models (Joshi et al. 2004).\n\nmeasuring electrical properties in Zebrafish embryos has\n\nTraditionally, patch clamp electrophysiology is regarded\n\nbeen developed (Forouhar et al. 2004). In the methodology,\n\nas the 'gold standard\u201d for measuring of ion channel activity\n\nfive day old embryos are mounted on their dorso-ventral\n\n(Fermini and Fossa. 2003). Patch clamp allows for the direct\n\norientation and two electrodes are positioned using a micro\n\nand real-time monitoring of ion channel activity in the\n\nmanipulator, one on the body Surface outside the heart and\n\n50\n\nadministration of testing compounds in whole-cell mode.\n\nanother reference electrode in the Surrounding solution.\n\nHowever, it is a low-throughput methodology and requires\n\nHowever, these methods are also time-consuming and labor\n\nhighly skillful operators. Although other advanced screening\n\nintensive, particularly in Sample preparation steps, making\n\ntechnologies have been developed recently to improve the\n\nthem not suitable for high throughput study.\n\ndegree of throughput, all these technologies are based on in\n\n55\n\nvitro cell culture models. The disadvantage of using in vitro\n\nSUMMARY OF THE INVENTION\n\nmodel is that complex physiological environment that\n\noccurs in vivo cannot be modeled in an in vitro system.\n\nThe invention relates to a method of using a teleost as\n\nSome biological questions of cardiac electrophysiology can\n\nmodel to screen agents for cardiotoxic effect, particularly\n\nnot simply be addressed by in vitro assays. In this case, in", "type": "Document"}}